Three specialty drug trends to prepare for: Biosimilars, gene and cell therapies, cancer drugs
Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...
Read More
Nurses Improve Health Outcomes
Whether nurses have direct interaction with patients or work in non-traditional roles, their knowledge and expertise can improve health outcomes for patients.
Read More
Improving Access to the Most Up-to-Date Cancer Care
Cancer treatment can be scary and complicated. Express Scripts is partnering with Labcorp to help ensure members have access to targeted and personalized treatments.
Read More
Express Scripts Further Advances Transparency and Affordability for Consumers and Clients
Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (...
Read More
Meet Eric Palmer, president and chief executive officer of Evernorth Health Services
Eric Palmer's career journey started with a summer internship at Cigna Healthcare. Today, he leads Evernorth Health Services, supporting employers and health plans in improving the health of their mem...
Read More
Boosting Biosimilars Competition and Savings
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Read More
How To Build a Quality Fertility Provider Network
Successful assisted reproduction requires specialized care and the ability to perform complex lab tests and genetic testing. Here’s what you need to know.
Read More
Copay Assistance Strategy Reduces Financial Burdens for Plans And Patients
Innovative solution provides $0 member cost for costly specialty drugs while reducing plans’ costs
Read More